Osteoprotegerin reduces the loss of periarticular bone mass in primary and secondary spongiosa but does not influence inflammation in rat antigen-induced arthritis.
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Objective To assess the effect of osteoprotegerin (OPG) on joint swelling, synovial inflammation and cartilage destruction, periarticular and axial bone volume, and bone turnover in rat antigen-induced arthritis (AIA).Design Rats were treated with OPG (3 mg/kg/day) at regular intervals from day 1 to day 20 of AIA. Disease activity was evaluated by measurement of joint swelling as well as, joint inflammation and destruction by histology. Bone volume and cellular turnover parameters of secondary spongiosa of the right tibia head and the third lumbar vertebra were evaluated by histomorphometry. Periarticular bone volume of the primary spongiosa at the right tibia head was measured by linear scanning. The findings were compared with those of PBS-treated AIA and healthy animals.Result OPG treatment did not reduce joint swelling or histological signs of inflammation. Cartilage destruction was reduced. However, this effect did not reach statistical significance . In the secondary spongiosa OPG treatment reduced the loss of periarticular bone volume. However, the latter did not reach the level of healthy controls. OPG treatment significantly reduced parameters of bone formation and bone resorption. In the primary spongiosa, OPG-treatment led to a higher amount of mineralized tissue and a greater number of trabeculae compared to PBS-treated animals with AIA or healthy controls. In the axial skeleton, OPG treatment reduced bone formation and bone resorption parameters compared to healthy animals. This treatment had no influence on bone volume.Conclusions In periarticular bone of AIA rats, OPG treatment reduced the loss of bone volume and decreased the bone turnover, thus preventing periarticular bone destruction. OPG treatment had no influence on inflammatory process or on cartilage destruction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“OPG was also shown to reduce periarticular bone loss in arthritic rats (235)”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [235]
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130 · cited 3×
“Fc-OPG is a chimeric molecule comprising amino acids 22–194 of human OPG, fused at N-terminus to the C-terminus of the Fc domain of human IgG1 [13], and covalently dimerized through the Fc domain.”
BackgroundYasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M. T., & Martin, T. J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0367 · Cited by 2,336
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290 · cited 3×
“family that is found on chondrocytes, dendritic cells, osteoclast precursors, and mature osteoclasts [6, 10].”
BackgroundKong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856 · cited 6×
“In the T cell-dependent model of rat adjuvant arthritis and in collagen-induced arthritis, blockade of RANKL through OPG treatment prevents bone and cartilage destruction but not infl ammation [16, 25].”
BackgroundResultInfluentialManolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,668 · cited 1×
“Osteoblasts support osteoclasts and regulate their activity by various cytokines [5].”
BackgroundHsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 3×
“Osteoprotegerin is known to have at least two roles: it inhibits osteoclast formation and activity and promotes apoptosis of mature osteoclasts [10, 35, 36].”
BackgroundYasuda, H., Shima, N., Nakagawa, N., Mochizuki, S.-I., Yano, K., Fujise, N., Sato, Y., Goto, M., Yamaguchi, K., Kuriyama, M., et al. (1998) · Endocrinology · doi:10.1210/endo.139.3.5837 · Cited by 1,201 · cited 1×
“Osteoprotegerin (OPG), isolated as a protein inhibiting bone resorption, is a secreted TNF receptor-related protein [13, 14].”
BackgroundLi, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119 · cited 1×
“RANK has been described as an essential signaling receptor for osteoclast formation [33].”
Background
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
Stolina, M., Schett, G. A., Dwyer, D., Vonderfecht, S. L., Middleton, S. C., Duryea, D., Pacheco, E., Van, G. Y., Bolon, B. N., Feige, U., et al. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2879 · Cited by 86
“Collectively, these observations add to a growing body of evidence indicating that RANKL does not regulate local inflammation in either AIA or CIA in rats, while further supporting the premise that RANKL is a common and important downstream mediator of local and systemic bone loss in these models [16,21,24-26].”
BackgroundKolahi, S., Ghorbanihaghjo, A., Alizadeh, S., Rashtchizadeh, N., Argani, H., Khabazzi, A.-R., Hajialilo, M., & Bahreini, E. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.12.011 · Cited by 66
Yuan, H., Gupte, R. K., Zelkha, S., & Amar, S. (2011) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2011.01780.x · Cited by 62
“Indeed a previous report using OPG-Fc in a rat model to treat rheumatoid arthritis reported a lack of reduction of cytokines in these animals (Neumann et al. 2006).”
MethodResultMarenzana, M., Vugler, A., Moore, A., & Robinson, M. K. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4305 · Cited by 54
“This is consistent with other studies where bone-specific treatments have failed to modulate immune reactions [15,26-29].”
Result
Metadata
- Authors
- Neumann, T., Oelzner, P., Petrow, P. K., Thoss, K., Hein, G., Stein, G., & Bräuer, R.
- Affiliations
- Friedrich Schiller University Jena (DE)
- Corresponding author
- Neumann, T.
- Venue
- Inflammation Research
- Published
- 2006-01
- Volume
- 55
- Issue
- 1
- Pages
- 32-39
- ISSN
- 1023-3830 (ISSN-L)
- 1420-908X
- OpenAlex
- W1973207129
- Cited by
- 12
- References
- 39
- Citations by year
- 2020: 1 · 2019: 1 · 2016: 1 · 2014: 1 · 2013: 1
- FWCI
- 0.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Inflammation Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- osteoprotegerin, antigen-induced arthritis, periarticular bone loss, bone turnover, bone formation, bone resorption, synovitis, cartilage destruction, trabecular bone, axial skeleton, rat model
- MeSH terms
- Animals, Antigens, Arthritis, Experimental, Bone and Bones, Bone Diseases, Disease Models, Animal, Female, Inflammation, Knee Joint, Rats, Inbred Lew, Time Factors, Rats, Osteoprotegerin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Osteoprotegerin reduces the loss of periarticular bone mass in primary and secondary spongiosa but does not influence inflammation in rat antigen-induced arthritis. https://app.cochat.ai/papers/10.1007/s00011-005-0005-5
- The paper
- Neumann, T., Oelzner, P., Petrow, P. K., Thoss, K., Hein, G., Stein, G., & Bräuer, R. (2006). Osteoprotegerin reduces the loss of periarticular bone mass in primary and secondary spongiosa but does not influence inflammation in rat antigen-induced arthritis. Inflammation Research. https://doi.org/10.1007/s00011-005-0005-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.